BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 23
  • This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (8263)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.
Item 
Count 
PDF457
WORD198
HTML4074
Figures (1-1)513
Tables (1-2)525
 Sum=5767
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1253
Download1243
 Sum=2496
Jun 21, 2014 (publication date) through Dec 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7079-7088
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7079
Table 1 Protease inhibitors currently under development
First generation (wave 2)
Simeprevir
Faldaprevir
Danoprevir
Vaniprevir
ABT-450/ABT-450r
Asunaprevir
Second generation
MK-5172
ACH-2684
Full Size Table
Table 2 Additional drugs in development for hepatitis C
NS5A hepatitis C virus replication inhibitors
Daclatasvir
Ledipasvir
ACH-3102
ABT-267
NS5B RNA dependent RNA polymerase inhibitors
Sofosbuvir
Mericitabine
ABT-333
Host targeted agents
Alisporivir
Miravirsen
Interferon-λ
Full Size Table
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345